ID IRS1_CHLAE Reviewed; 1251 AA.
AC Q28224;
DT 29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1996, sequence version 1.
DT 04-NOV-2026, entry version 110.
DE RecName: Full=Insulin receptor substrate 1;
DE Short=IRS-1;
GN Name=IRS1;
OS Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC Cercopithecidae; Cercopithecinae; Chlorocebus.
OX NCBI_TaxID=9534;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=7488107; DOI=10.1006/bbrc.1995.2627;
RA Wang L., Hayashi H., Mitani Y., Ishii K., Ohnishi T., Niwa Y., Kido H.,
RA Ebina Y.;
RT "Cloning of a cDNA encoding a 190-kDa insulin receptor substrate-1-like
RT protein of simian COS cells.";
RL Biochem. Biophys. Res. Commun. 216:321-328(1995).
CC -!- FUNCTION: Signaling adapter protein that participates in the signal
CC transduction from two prominent receptor tyrosine kinases, insulin
CC receptor/INSR and insulin-like growth factor I receptor/IGF1R. Plays
CC therefore an important role in development, growth, glucose homeostasis
CC as well as lipid metabolism. Upon phosphorylation by the insulin
CC receptor, functions as a signaling scaffold that propagates insulin
CC action through binding to SH2 domain-containing proteins including the
CC p85 regulatory subunit of PI3K, NCK1, NCK2, GRB2 or SHP2 (By
CC similarity). Recruitment of GRB2 leads to the activation of the guanine
CC nucleotide exchange factor SOS1 which in turn triggers the
CC Ras/Raf/MEK/MAPK signaling cascade (By similarity). Activation of the
CC PI3K/AKT pathway is responsible for most of insulin metabolic effects
CC in the cell, and the Ras/Raf/MEK/MAPK is involved in the regulation of
CC gene expression and in cooperation with the PI3K pathway regulates cell
CC growth and differentiation (By similarity). Acts a positive regulator
CC of the Wnt/beta-catenin signaling pathway through suppression of DVL2
CC autophagy-mediated degradation leading to cell proliferation (By
CC similarity). {ECO:0000250|UniProtKB:P35568,
CC ECO:0000250|UniProtKB:P35570}.
CC -!- SUBUNIT: Interacts with UBTF and PIK3CA (By similarity). Interacts (via
CC phosphorylated YXXM motifs) with PIK3R1 (By similarity). Interacts with
CC ROCK1 and FER (By similarity). Interacts (via PH domain) with PHIP (By
CC similarity). Interacts with GRB2 (By similarity). Interacts with SOCS7.
CC Interacts (via IRS-type PTB domain) with IGF1R and INSR (via the
CC tyrosine-phosphorylated NPXY motif). Interacts with ALK (By
CC similarity). Interacts with EIF2AK2/PKR (By similarity). Interacts with
CC GKAP1 (By similarity). Interacts with DGKZ in the absence of insulin;
CC insulin stimulation decreases this interaction (By similarity). Found
CC in a ternary complex with DGKZ and PIP5K1A in the absence of insulin
CC stimulation (By similarity). Interacts with SQSTM1; the interaction is
CC disrupted by the presence of tensin TNS2. Interacts with NCK1 (via SH2
CC domain). Interacts with NCK2 (via SH3 domain) (By similarity).
CC Interacts with SH2B1; this interaction enhances leptin-induced
CC activation of the PI3-kinase pathway (By similarity). Interacts with
CC DVL2; this interaction promotes the Wnt/beta-catenin signaling pathway
CC (By similarity). Interacts with JAK1 (By similarity).
CC {ECO:0000250|UniProtKB:P35568, ECO:0000250|UniProtKB:P35569,
CC ECO:0000250|UniProtKB:P35570}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P35568}. Nucleus
CC {ECO:0000250|UniProtKB:P35568}. Note=Nuclear or cytoplasmic
CC localization of IRS1 correlates with the transition from proliferation
CC to chondrogenic differentiation. {ECO:0000250|UniProtKB:P35568}.
CC -!- PTM: Serine phosphorylation of IRS1 is a mechanism for insulin
CC resistance. Ser-312 phosphorylation inhibits insulin action through
CC disruption of IRS1 interaction with the insulin receptor (By
CC similarity). Phosphorylation of Tyr-905 is required for GRB2-binding
CC (By similarity). Phosphorylated by ALK. Phosphorylated at Ser-270, Ser-
CC 307, Ser-636 and Ser-1109 by RPS6KB1; phosphorylation induces
CC accelerated degradation of IRS1. Phosphorylated on tyrosine residues in
CC response to insulin (By similarity). In skeletal muscles,
CC dephosphorylated on Tyr-612 by TNS2 under anabolic conditions;
CC dephosphorylation results in the proteasomal degradation of IRS1 (By
CC similarity). {ECO:0000250|UniProtKB:P35568,
CC ECO:0000250|UniProtKB:P35569, ECO:0000250|UniProtKB:P35570}.
CC -!- PTM: Ubiquitinated by the Cul7-RING(FBXW8) complex in a mTOR-dependent
CC manner, leading to its degradation: the Cul7-RING(FBXW8) complex
CC recognizes and binds IRS1 previously phosphorylated by S6 kinase
CC (RPS6KB1 or RPS6KB2). Ubiquitinated by TRAF4 through 'Lys-29' linkage;
CC this ubiquitination regulates the interaction of IRS1 with IGFR and
CC IRS1 tyrosine phosphorylation upon IGF1 stimulation (By similarity).
CC {ECO:0000250|UniProtKB:P35568}.
CC -!- PTM: S-nitrosylation at by BLVRB inhibits its activity.
CC {ECO:0000250|UniProtKB:P35568}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; D64157; BAA11026.1; -; mRNA.
DR AlphaFoldDB; Q28224; -.
DR BMRB; Q28224; -.
DR SMR; Q28224; -.
DR IntAct; Q28224; 1.
DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR GO; GO:0005829; C:cytosol; IEA:TreeGrafter.
DR GO; GO:0043231; C:intracellular membrane-bounded organelle; ISS:UniProtKB.
DR GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR GO; GO:0005886; C:plasma membrane; IEA:TreeGrafter.
DR GO; GO:0005158; F:insulin receptor binding; ISS:UniProtKB.
DR GO; GO:0005159; F:insulin-like growth factor receptor binding; ISS:UniProtKB.
DR GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; ISS:UniProtKB.
DR GO; GO:0042169; F:SH2 domain binding; ISS:UniProtKB.
DR GO; GO:0030159; F:signaling receptor complex adaptor activity; IEA:UniProtKB-ARBA.
DR GO; GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB.
DR GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISS:UniProtKB.
DR GO; GO:0009967; P:positive regulation of signal transduction; IEA:UniProtKB-ARBA.
DR CDD; cd01257; PH_IRS; 1.
DR CDD; cd01204; PTB_IRS; 1.
DR FunFam; 2.30.29.30:FF:000029; Insulin receptor substrate 1; 1.
DR FunFam; 2.30.29.30:FF:000129; Insulin receptor substrate 1; 1.
DR Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR InterPro; IPR039011; IRS.
DR InterPro; IPR002404; IRS_PTB.
DR InterPro; IPR011993; PH-like_dom_sf.
DR InterPro; IPR001849; PH_domain.
DR PANTHER; PTHR10614; INSULIN RECEPTOR SUBSTRATE; 1.
DR PANTHER; PTHR10614:SF11; INSULIN RECEPTOR SUBSTRATE 1; 1.
DR Pfam; PF02174; IRS; 1.
DR Pfam; PF00169; PH; 1.
DR PRINTS; PR00628; INSULINRSI.
DR SMART; SM01244; IRS; 1.
DR SMART; SM00233; PH; 1.
DR SMART; SM00310; PTBI; 1.
DR SUPFAM; SSF50729; PH domain-like; 2.
DR PROSITE; PS51064; IRS_PTB; 1.
DR PROSITE; PS50003; PH_DOMAIN; 1.
PE 2: Evidence at transcript level;
KW Cytoplasm; Isopeptide bond; Nucleus; Phosphoprotein; Repeat;
KW S-nitrosylation; Transducer; Ubl conjugation.
FT CHAIN 1..1251
FT /note="Insulin receptor substrate 1"
FT /id="PRO_0000084234"
FT DOMAIN 12..115
FT /note="PH"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT DOMAIN 160..264
FT /note="IRS-type PTB"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00389"
FT REGION 3..137
FT /note="Mediates interaction with PHIP"
FT /evidence="ECO:0000250"
FT REGION 262..430
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 494..513
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 594..616
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 668..692
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 734..753
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 769..946
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 905..907
FT /note="GRB2-binding"
FT /evidence="ECO:0000250"
FT REGION 1091..1124
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1130..1149
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1195..1251
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOTIF 465..468
FT /note="YXXM motif 1"
FT MOTIF 551..554
FT /note="YXXM motif 2"
FT MOTIF 612..615
FT /note="YXXM motif 3"
FT MOTIF 632..635
FT /note="YXXM motif 4"
FT MOTIF 662..665
FT /note="YXXM motif 5"
FT MOTIF 730..733
FT /note="YXXM motif 6"
FT MOTIF 950..953
FT /note="YXXM motif 7"
FT MOTIF 998..1001
FT /note="YXXM motif 8"
FT MOTIF 1021..1024
FT /note="YXXM motif 9"
FT COMPBIAS 269..281
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 354..363
FT /note="Basic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 383..404
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 412..424
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 594..610
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 668..692
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 774..783
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 799..813
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 875..891
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 924..937
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1111..1123
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1207..1218
FT /note="Pro residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOD_RES 3
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 99
FT /note="Phosphoserine; by CK2"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 270
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 307
FT /note="Phosphoserine; by RPS6KB1"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 312
FT /note="Phosphoserine; by IKKB, MAPK8 and RPS6KB1"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 323
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 330
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35569"
FT MOD_RES 345
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35569"
FT MOD_RES 348
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 419
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35569"
FT MOD_RES 446
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 453
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 465
FT /note="Phosphotyrosine; by INSR"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 527
FT /note="Phosphoserine; by RPS6KB1"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 612
FT /note="Phosphotyrosine; by INSR"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 629
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 632
FT /note="Phosphotyrosine; by INSR"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 636
FT /note="Phosphoserine; by RPS6KB1"
FT /evidence="ECO:0000250|UniProtKB:P35569"
FT MOD_RES 662
FT /note="Phosphotyrosine"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 792
FT /note="Phosphoserine; by AMPK and SIK2"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 901
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35569"
FT MOD_RES 905
FT /note="Phosphotyrosine; by INSR"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 950
FT /note="Phosphotyrosine; by INSR"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 998
FT /note="Phosphotyrosine; by INSR"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 1109
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35569"
FT MOD_RES 1110
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P35568"
FT MOD_RES 1188
FT /note="Phosphotyrosine; by INSR"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT MOD_RES 1238
FT /note="Phosphotyrosine; by INSR"
FT /evidence="ECO:0000250|UniProtKB:P35570"
FT CROSSLNK 1195
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in ubiquitin)"
FT /evidence="ECO:0000250|UniProtKB:P35568"
SQ SEQUENCE 1251 AA; 133054 MW; 924CCAC3BE68EB98 CRC64;
MASPPESDGF SDVRKVGYLR KPKSMHKRFF VLRAASETGD PARLEYYENE KKWRHKSSAP
KRSIPLESCF NINKRADSKN KHLVALYTRD EHFAIAADSE AEQDSWYQAL LQLHNRAKGH
HDGAAALGAG GGGGSCSGSS GLGEAGEDLS YGDVPPGPAF KEVWQVILKP KGLGQTKNLI
GIYRLCLTSK TISFVKLNSE AAAVVLQLMN IRRCGHSENF FFIEVGRSAV TGPGEFWMQV
DDSVVAQNMH ETILEAMRAM SDEFRPRSKS QSSSNCSNPI SVPLRRHHLN NPPPSQVGLT
RRSRTESITA TSPASMVGGK PGSFRVRASS DGEGTMSRPA SVDGSPVSPS TNRTHAHRHR
GSARLHPPLN HSRSIPMPAS RCSPSATSPV SLSSSSTSGH GSTSDCLFPR RSSASVSGSP
SDGGFISSDE YGSSPCDFRS SFRSVTPDSL GHTPPARGEE ELSNYICMGG KGPSTLTAPN
GHYILSRGGN GHRYTPGTGL GTSPALAGDE ASSAADLDNR FRKRTHSAGT SPTITHQKTP
SQSSVASIEE YTEMMPAYPP GGGSGGRLPG HRHSAFVPTH SYPEEGLEMH PLERRGGHHR
PDSSTLHTDD GYMPMSPGVA PVPSSRKGSG DYMPMSPKSV SAPQQIINPI RRHPQRVDPN
GYMMMSPSGG CSPDIGGGPS SSSSSTVPSG SSYGKLWTKG VGAHNSQVLL HPKPPVESSG
GKLLPCTGDY MNMSPVGDSN TSSPSDCYYG PEDPQHKPVL SYYSLPRSFK HTQRPGEPEE
GARHQHLRLS TSSGRLLYAA TADDSSSSTS SDSLGGGYCG ARLEPSLPHP HHQVLQPHLP
RKVDTAAQTN SRLARPTRLS LGDPKASTLP RAREQQQQQQ QQQQQQQQQQ QPLLHPPEPK
SPGEYVNIEF GSDQPGYLSG PVASRSSPSV RCPSQLQPAP REEETGTEEY MKMDLGPGRR
AAWQESTGVE MGRLGPAPPG AASICRPTRA VPSSRGDYMT MQMSCPRQSY VDTSPIAPVS
YADMRTGIAA EEVSLPRATM AAAASSSAAS ASPTGPQGAA ELAAHSSLLG GAQGPGGMSA
FTRVNLSPNR NQSAKVIRAD PQGCRRRHSS ETFSSTPSAT RVGNTVPFGA GAAIGGSGGS
SSSSEDVKRH SSASFENVWL RPGELGGAPK EPAQLCGAAG GLENGLNYID LDLVKDFKQR
PQECTPQPQP PPPPPPHQPL GSSESSSTRR SSEDLSAYAS ISFQKQPEDL Q
//